Average Co-Inventor Count = 12.15
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Inc. (7 from 822 patents)
2. Abbott Laboratories Corporation (5 from 4,179 patents)
3. Enanta Pharmaceuticals, Inc. (3 from 292 patents)
4. Reata Pharmaceuticals, Inc. (1 from 61 patents)
5. Enata Pharmacueticals, Inc. (1 from 1 patent)
6. Abbvie Bahamas Limited (6 patents)
7. Abbvie Ireland Unlimited Company (0 patent)
12 patents:
1. 9493506 - Macrocyclic hepatitis C serine protease inhibitors
2. 9464082 - Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
3. 9309279 - Macrocyclic hepatitis C serine protease inhibitors
4. 8951964 - Phenanthridine macrocyclic hepatitis C serine protease inhibitors
5. 8748374 - Macrocyclic hepatitis C serine protease inhibitors
6. 8642538 - Macrocyclic hepatitis C serine protease inhibitors
7. 8497275 - HCV protease inhibitors and uses thereof
8. 8420596 - Macrocyclic hepatitis C serine protease inhibitors
9. 8338605 - Anti-viral compounds
10. 7915411 - Anti-viral compounds
11. 7910595 - Anti-viral compounds
12. 7763731 - Anti-viral compounds